Celldex Therapeutics, Inc. — All Filings
1,002 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-K405
10-Q
10-Q/A
144
3
4
4/A
424B1
424B2
424B3
424B5
425
5
8-A12G
8-A12G/A
8-K
8-K/A
ARS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFR14A
DEL AM
EFFECT
NT 10-K
NT 10-Q
POS AM
PRE 14A
REGDEX
S-3
S-3/A
S-3ASR
S-3MEF
S-4
S-4/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-000983 | Mar 26, 2026 | — |
| SCHEDULE 13G/A | — | 0000902664-26-001544 | Mar 10, 2026 | — |
| 10-K | 10-K | 0001104659-26-019652 | Feb 25, 2026 | Dec 31, 2025 |
| 8-K | FORM 8-K | 0001171843-26-001098 | Feb 25, 2026 | — |
| SCHEDULE 13G/A | — | 0000902219-26-000058 | Feb 10, 2026 | — |
| 4 | — | 0001709024-26-000002 | Jan 6, 2026 | Jan 2, 2026 |
| 4 | — | 0001214504-25-000007 | Dec 17, 2025 | Dec 15, 2025 |
| 4 | — | 0001838114-25-000007 | Dec 8, 2025 | Dec 4, 2025 |
| 144 | — | 0001950047-25-009745 | Dec 4, 2025 | — |
| 4 | — | 0001646423-25-000007 | Nov 17, 2025 | Nov 13, 2025 |
| SCHEDULE 13G | — | 0001104659-25-112821 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001831942-25-000031 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000080255-25-000800 | Nov 14, 2025 | — |
| 144 | — | 0001950047-25-008818 | Nov 13, 2025 | — |
| 4 | — | 0001960596-25-000008 | Nov 12, 2025 | Nov 10, 2025 |
| 3 | — | 0001960596-25-000006 | Nov 12, 2025 | Nov 10, 2025 |
| 10-Q | 10-Q | 0001104659-25-109137 | Nov 10, 2025 | Sep 30, 2025 |
| 8-K | FORM 8-K | 0001171843-25-007179 | Nov 10, 2025 | — |
| SCHEDULE 13G/A | — | 0000902219-25-000372 | Nov 7, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-080248 | Aug 19, 2025 | — |
| 4 | — | 0001415889-25-022069 | Aug 15, 2025 | Aug 13, 2025 |
| SCHEDULE 13G/A | — | 0001580642-25-005132 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000902219-25-000286 | Aug 12, 2025 | — |
| 10-Q | 10-Q | 0001410578-25-001610 | Aug 7, 2025 | Jun 30, 2025 |
| 8-K | FORM 8-K | 0001171843-25-005181 | Aug 7, 2025 | — |
| SCHEDULE 13G | — | 0000902664-25-002963 | Jul 10, 2025 | — |
| 4 | — | 0001415889-25-016260 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | — | 0001415889-25-016257 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | — | 0001415889-25-016255 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | — | 0001415889-25-016244 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | — | 0001415889-25-016242 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | — | 0001415889-25-016241 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | — | 0001415889-25-016238 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | — | 0001415889-25-016230 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | — | 0001415889-25-016227 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | — | 0001415889-25-016226 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | — | 0001415889-25-016225 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | — | 0001415889-25-016222 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | — | 0001415889-25-016220 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | — | 0001415889-25-016219 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | — | 0001415889-25-016217 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | — | 0001415889-25-016216 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | — | 0001415889-25-016215 | Jun 9, 2025 | Jun 5, 2025 |
| S-8 | FORM S-8 | 0001104659-25-057296 | Jun 6, 2025 | — |
| 3 | OWNERSHIP DOCUMENT | 0001104659-25-057069 | Jun 6, 2025 | Jun 5, 2025 |
| 8-K | FORM 8-K | 0001104659-25-057066 | Jun 6, 2025 | Jun 5, 2025 |
| SCHEDULE 13G/A | — | 0001085146-25-003253 | May 15, 2025 | — |
| SCHEDULE 13G/A | — | 0000902219-25-000176 | May 12, 2025 | — |
| 10-Q | 10-Q | 0001410578-25-001111 | May 8, 2025 | Mar 31, 2025 |
| 8-K | FORM 8-K | 0001171843-25-002980 | May 8, 2025 | — |